Firehawk DES: proven fast healing from TARGET clinical programme

Chairpersons: M.B. Leon, W. Wijns


To understand the novel technology of an abluminal groove-filled biodegradable polymer DES
To learn about the up-to-date clinical data on the Firehawk stent
To discuss the potential benefits for our patients by using this novel technology


Session objectives and FireHawk DES clinical programme

M.B. Leon

Shared cases from the TARGET all-comer trial

A. Baumbach

New release - Three-month OCT follow-up result from the randomised TARGET all-comer trial

W. Wijns

Updates on the five-year TARGET I randomised clinical trial and five-year TARGET II follow-up results

B. Xu

Session evaluation and key learnings

W. Wijns


More from Microport

Visit website